# 510(k) Summary, cobas 8000 ISE Calibration Change and Measuring Range Extension

Continued on next page

# 510(k) Summary: ccbas 8000 ISE Calibration Change and Measuring Range Extension, continued

# Introduction

The information in this 510(k) summary is being submitted in accordance with requirements of 21 CFR 807.92.

# Submitter name, address, and contact

Roche Diagnostics 9115 Hague Road Indianapolis, IN 46250

Contact person: David Tribbett Phone: 317-521-2964 Fax: 317-521-2324

Date Prepared: May 8, 2014

# Device name

# Proprietary name:

cobas 8000 ISE Indirect Na, K, CI for Gen. 2.

# Common name:

Sodium Test System Potassium Test System Chloride Test System

# Classification:

Ion-Specific Electrode Sodium Ion-Specific Electrode Potassium Ion-Specific Electrode Chloride

# Establishment registration

For the cobas 8000 ISE module, the establishment registration number for Roche Diagnostics GmbH in Mannheim, Germany is 9610126. The establishment registration number for Roche Diagnostics, United States is 1823260.

Continued on next page

# 510(k) Summary: cobas 8000 ISE Calibration Change and Measuring Range Extension, continued

# Classification

The FDA has classified the Sodium, Potassium, and Chloride Test Systems as Class II devices.

<table><tr><td rowspan=1 colspan=1>Panel</td><td rowspan=1 colspan=1>ProductCode</td><td rowspan=1 colspan=1>Classification Name</td><td rowspan=1 colspan=1>Regulation</td></tr><tr><td rowspan=1 colspan=1>ClinicalChemistry (75)</td><td rowspan=1 colspan=1>JGS</td><td rowspan=1 colspan=1>Ion Specific Electrode, Sodium</td><td rowspan=1 colspan=1>21 CFR862.1665</td></tr><tr><td rowspan=1 colspan=1>ClinicalChemistry (75)</td><td rowspan=1 colspan=1>CEM</td><td rowspan=1 colspan=1>Ion Specific Electrode,Potassium</td><td rowspan=1 colspan=1>21 CFR862.1600</td></tr><tr><td rowspan=1 colspan=1>ClinicalChemistry (75)</td><td rowspan=1 colspan=1>CGZ</td><td rowspan=1 colspan=1>Ion Specific Electrode, Chloride</td><td rowspan=1 colspan=1>21 CFR862.1170</td></tr></table>

# Proposed labeling

Draft labeling sufficient to describe the device, its intended use, and the directions for use on the cobas 8000 ISE analyzer module for serum, plasma, and urine samples is included in the submission.

Device description

The cobas 8000 ISE module is an lon-Selective Electrode (ISE) system for the determination of sodium, potassium, and chloride in serum, plasma, and urine. The cobas 8000 ISE module and the ISE Gen 2 reagents were previously cleared for serum and plasma sample types under K100853 and urine sample type on K123726.

This premarket notification seeks to obtain FDA review and clearance for the urine sample type for the ISE Gen 2 reagents on the cobas 8000 ISE module using an expanded measuring range for sodium and chloride analytes at the low end of the measuring range and the new calibration method cleared in K132418.

An ISE makes use of the unique properties of certain membrane materials to develop an electrical potential (electromotive force, EMF) for the measurements of ions in solution. The electrode has a selective membrane in contact with both the test solution and an internal filling solution. The internal filling solution contains the test ion at a fixed concentration. Because of the particular nature of the membrane, the test ions will closely associate with the membrane on each side. The membrane EMF is determined by the difference in concentration of the test ion in the test solution and the internal filling solution. The EMF develops according to the Nernst equation for a specific ion in solution (see package insert for further explanation). Please refer to K100853 for detailed hardware and software information relating to the cobas 8000 modular analyzer series.

Commercially available controls are recommended for the urine sample type. Aqueous ISE standards Low and High were cleared under K053165. The LHH calibration scheme was cleared under K132418.

# 510(k) Summary: cobas 8000 ISE Calibration Change and Measuring Range Extension, continued

# Intended use

The ISE module of the Roche/Hitachi cobas c system is intended for the quantitative determination of sodium, potassium and chloride in serum, plasma or urine using ion-selective electrodes.

# Indications for use

The cobas 8000 ISE module is a fully automated ion-specific analyzer intended for the in vitro potentiometric determination of chloride, potassium, and sodium in serum, plasma, and urine using ion-selective electrodes. Measurements obtained by this device are used in the diagnosis and treatment of diseases or conditions involving electrolyte imbalance.

# Substantial equivalence - comparison

The following tables compare the cobas 8000 ISE module using Low/High/High calibration and its predicate device the cobas 8000 ISE Module using Low/High/Serum Compensator calibration cleared under K123726.

Comparison of Systems similarities and differences   

<table><tr><td rowspan=1 colspan=3>System Comparison</td></tr><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>Predicate Devicecobas 8000 ISE Module (K123726)</td><td rowspan=1 colspan=1>Candidate Devicecobas 8000 ISE Module</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>The ISE module of the Roche/Hitachicobas c systems is intended for thequantitative determination of sodium,potassium and chloride in serum, plasmaor urine using ion-sclective electrodes.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Serum/Plasma/Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measurementprinciple</td><td rowspan=1 colspan=1>ISE Potentiometry</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reagentcontainer</td><td rowspan=1 colspan=1>Plastic bottles closed via screw caps</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Onboard storagetemperature</td><td rowspan=1 colspan=1>Room Temperature</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>ISE Module</td><td rowspan=1 colspan=1>Separate ISE module connected to Corecobas 8000 module</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Ion Selectiveelectrodes (ISEs)</td><td rowspan=1 colspan=1>Potentiometric chloride. potassium.sodjum and reference electrodes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Dilution(Serum/plasma)</td><td rowspan=1 colspan=1>1:31</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Dilution(Urine)</td><td rowspan=1 colspan=1>1:46 Standard Range</td><td rowspan=1 colspan=1>1:46 Standard Range1:31 Under Range Rerun</td></tr><tr><td rowspan=1 colspan=1>Throughput</td><td rowspan=1 colspan=1>Max 1800 tests/hour</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>CalibrationScheme</td><td rowspan=1 colspan=1>ISE Standard Low, High, SerumCompensator(LHSc)</td><td rowspan=1 colspan=1>ISE Standard Low, High.High(LHH)</td></tr></table>

# 510(k) Summary: cobas 8000 ISE Calibration Change and Measuring Range Extension, continued

Comparison of assays - similarities and differences   

<table><tr><td colspan="7">Assay Comparison Sodium</td></tr><tr><td>Parameter</td><td colspan="3">Predicate Device cobas 8000 Urine ISE LHSc Calibration Method (K123726) Mean</td><td colspan="4">Candidate Device cobas 8000 Urine ISE LHH</td></tr><tr><td>Repeatability</td><td rowspan="6">Low Med High Liq 1 Liq 2 170.6</td><td rowspan="3">[mmol/L] 66.4 178.9 0.3 0.5</td><td rowspan="6">SD [%]</td><td>CV</td><td colspan="3">Calibration Method Mean SD</td></tr><tr><td>[mmol/L] 0.4</td><td></td><td>[mmol/L] [mmol/L]</td><td>CV [%]</td></tr><tr><td>0.6</td><td>Low 69.9</td><td>0.2</td><td>0.3</td></tr><tr><td>0.9 0.7</td><td>0.5 Med</td><td>174.5</td><td>0.5</td><td>0.3</td></tr><tr><td rowspan="2">321.7 81.1</td><td>0.2</td><td>High 347.2</td><td>0.9</td><td>0.3</td></tr><tr><td>0.4 Liq !</td><td>83.4</td><td>0.3 1.3</td><td>0.3 0.8</td></tr><tr><td rowspan="6"></td><td rowspan="3"></td><td rowspan="6"></td><td>Med</td><td></td><td>Under Range Rerun using increased sample: 0.2</td><td></td></tr><tr><td>Low</td><td>24.7 37.7</td><td>0.2</td><td>0.9 0.6</td></tr><tr><td>MDL</td><td>31.7</td><td>0.2</td><td>0.7</td></tr><tr><td></td><td>High Liq 1 diluted</td><td>56.8 42.1</td><td>0.4 0.3</td><td>0.6 0.6</td></tr><tr><td></td><td>Liq 2 diluted</td><td>32.2</td><td>0.3</td><td>0.8</td></tr><tr><td rowspan="8">Intermediate precision (CLSI) Low Med</td><td rowspan="4">Mean [mmol/L]</td><td rowspan="2">SD [mmol/L]</td><td>CV</td><td>Mean</td><td>SD</td><td>CV</td></tr><tr><td>|%|</td><td>[mmol/L]</td><td>[mmol/L]</td><td>[%}</td></tr><tr><td>68.6</td><td>1.1 1.6</td><td>Low 69.9</td><td>1.3</td><td>1.8</td></tr><tr><td>180.3</td><td>1.0 0.6</td><td>Med</td><td>174.5</td><td>1.1 0.7</td></tr><tr><td>High 318.0</td><td>2.1</td><td>0.7 High</td><td>347.2</td><td>2.8 0.8</td></tr><tr><td>Liq I 82.7</td><td>1.2 1.4 0.6</td><td>Liq 1</td><td>83.4</td><td>1.3 1.6</td></tr><tr><td>Liq 2 171.3</td><td>1.0</td><td>Liq 2</td><td>175.6</td><td>1.7 1.0</td></tr><tr><td rowspan="7"></td><td rowspan="7"></td><td rowspan="7"></td><td rowspan="7">Low</td><td colspan="3">0.9</td></tr><tr><td>Med MDL 31.7</td><td>24.7 37.7</td><td>3.7 1.0 2.7 1.0</td></tr><tr><td>High</td><td>56.8</td><td>3.0 1.1 1.9</td></tr><tr><td>Liq 1</td><td>42.1</td><td>1.0 2.5 3.9</td></tr><tr><td>diluted Liq 2</td><td>32.2</td><td></td></tr><tr><td>N = 59</td><td>diluted N = 106</td><td>1.0</td></tr><tr><td>Correlation = 0.9997 Slopc (Bablok) = 0.976</td><td>Days = 2 Correlation = 0.9995</td><td></td></tr><tr><td rowspan="5">photometer) Method comparison to predicate</td><td colspan="2">Range (X)= 65.7 - 327.7 N = 59 Days = 2</td><td>Intercept (Bablok) = 4.3548</td><td></td><td>Slope (Bablok) = 0.997 Intercept (Bablok) = 0.984 Range (X) = 69.2 - 337.4</td><td></td></tr><tr><td colspan="2"></td><td colspan="2"></td><td colspan="2">N = 92</td></tr><tr><td colspan="2">Correlation = 0.9996 Slopc (Bablok) = 0.930</td><td colspan="2"></td><td colspan="2">Days = 2 Correlation = 0.9999</td></tr><tr><td colspan="2">Intercept (Bablok) = 12.0671 Range (X) = 63.8 - 339.2</td><td rowspan="2"></td><td colspan="3">Slope (Bablok) = 1.021 Intercept (Bablok) = -4.562 Range (X) = 65.3 - 342.1</td></tr><tr><td colspan="2">LOB = 7.6 mmol/L.</td><td colspan="3">LOB = 8.1 mmol/L</td></tr><tr><td>Limits</td><td colspan="2">LOD = 8.9 mmol/L</td><td colspan="3">LOD = 9.8 mmol/L</td></tr><tr><td rowspan="2">Standard Measuring</td><td colspan="2">LOQ = 23.2 mmol/L 60-350 mmol/l.</td><td rowspan="2"></td><td colspan="3">LOQ = 15.5 mmol/L 60-350 mmol/L</td></tr><tr><td colspan="2">No Extended Range</td><td colspan="3">20-59.9 mmol/L</td></tr></table>

# 510(k) Summary: cobas 8000 ISE Calibration Change and Measuring Range Extension, continued

Comparison of assays - similarities and differences   

<table><tr><td colspan="8">Assay Comparison Potassium</td></tr><tr><td>Parameter</td><td colspan="3">Predicate Device cobas 8000 Urine ISE LHSc Calibration Method (K123726)</td><td colspan="3">Candidate Device cobas 8000 Urine ISE LHH Calibration Method</td></tr><tr><td>Repeatability</td><td>Mean [mmol/L] Low 3.65 Med 51.10 High 83.78 Liq 1 32.19 Liq 2 69.47</td><td>SD [mmol/L] 0.00 0.30 0.66 019 0.39</td><td>CV [%] 1.2 Low 0.6 Med 0.8 High 0.6 Liq ! 0.6 Liq 2</td><td>Mean [mmol/L] 3.47 50.70 93.48 30.64 66.22</td><td>SD [mmol/L] 0.01 0.26 0.58 0.20 0.61</td><td>CV [%] 0.3 0.5 0.6 0.6 0.9</td></tr><tr><td>Intermediate precision (CLSI)</td><td>Mean [mmol/L] Low 3.75 Med 49.48 High 80.60 Liq I 31.32 Liq 2 67.49</td><td>SD [mmol/L] 0.06 0.65 1.32 0.37 1.17</td><td>CV [%] 1.7 Low 1.3 Med 1.6 High 1.2 Liq I 1.7 Liq 2</td><td>Mean [mmol/L] 3.47 50.70 93.48 30.64 66.22</td><td>SD [mmol/L] 0.04 0.63 1.82 0.32 1.14</td><td>CV [%] 1.1 1.2 1.9 1.0 1.7</td></tr><tr><td>Method Comparison to reference (flame photometry)</td><td colspan="2">N = 59 Days = 2 Correlation = 0.9993 Slopc (Bablok) = 0.962 Intercept (Bablok) = 1.7605</td><td colspan="4">N = 99 Days = 2 Correlation = 0.9997 Slope (Bablok) = 1.014 Intercept (Bablok) = 0.507</td></tr><tr><td>Method comparison to predicate</td><td colspan="3">Range (X) = 4.20 - 91.90 N = 59 Days = 2 Correlation = 0.9997 Slope (Bablok) = 0.920 Intercept (Bablok) = 1.4589</td><td colspan="3">Range (X) = 3.80 - 86.30 N= 92 Days = 2 Correlation = 0.9998 Slope (Bablok) = 1.021 Intercept (Bablok) = -0.208</td></tr><tr><td>Detection Limits</td><td colspan="3">Range (X)= 3.98 - 97.74 LOB = 0.3 mmol/L LOD = 0.4 mmol/L LOQ = 2.3 mmol/L</td><td colspan="3">Range (X) = 4.87 - 96.94 LoB = 0.3 mmol/L LoD = 0.4 mmol/L LoQ = 1.1 mmol/l</td></tr><tr><td>Reportable range</td><td colspan="3">3-100 mmol/l</td><td colspan="3">3-100 mmol/l</td></tr><tr><td>Extended Range</td><td colspan="3">No Extended Range</td><td colspan="3">No Extended Range</td></tr></table>

# 510(k) Summary: cobas 8000 ISE Calibration Change and Measuring Range Extension, continued

Comparison of assays - similarities and differences

<table><tr><td rowspan=1 colspan=3>Assay ComparisonChloride</td></tr><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>Predicate Devicecobas 8000 Urine ISE LHScCalibration Method (K123726)</td><td rowspan=1 colspan=1>Candidate Devicecobas 8000 Urine ISE LHHCalibration Method</td></tr><tr><td rowspan=1 colspan=1>Repeatability</td><td rowspan=1 colspan=1>Mean      SD     CV[mmol/L][mmol/L] [%]Low    63.6      0.5     0.7Med    180.8      0.9     0.5Hligh    341.7      1.1     0.3Liq 1    92.3       0.4     0.5Liq 2   189.6      0.6     0.3</td><td rowspan=1 colspan=1>Mean      SD     CV[mmol/L|[mmol/L] [%]Low    65.3       0.3     0.4Med    167.6      0.5     0.3High   333.5      1.6     0.5Liq 1   97.5      0.5     0.5Liq 2   193.2      1.5     0.8Under Range Rerun using increased sample:Low    21.6      0.2     1.0Med    34.2      0.3     0.9MDL    28.0       0.2     0.9High    55.0      0.4     0.8Liq 1    43.7       0.3     0.7DilutedLiq 2   29.0      0.4     1.5Diluted</td></tr><tr><td rowspan=1 colspan=1>Intermediateprecision(CLSI)</td><td rowspan=1 colspan=1>Mean      SD     CV[mmol/L][mmol/L] [%]Low    64.7       1.1     1.7Med    179.7      1.2     0.7HHigh   336.5      3.5     1.0[Liq 1    92.6       1.1     1.2Liq 2   187.6      1.6     0.9</td><td rowspan=1 colspan=1>Mean      SD     CV[mmol/L] [mmol/L] [%]Low    65.3      0.9     1.3Med   167.6      1.1     0.7High    333.5      3.5     1.0Liq I   97.5      0.9     0.9Liq 2   193.2      2.0     1.0Under Range Rerun using increased sample:Low    21.6      0.8     3.7Med    34.2      0.9     2.5MDL    28.0       0.8     3.0High    55.0       0.9     1.7Liq 1    43.7       1.0     2.3DilutedLiq 2   29.0      0.9     3.2 Diluted</td></tr><tr><td rowspan=1 colspan=1>MethodComparisonto reference(coulometry)</td><td rowspan=1 colspan=1>N=59Days = 2Correlation = 0.9985Slope (Bablok) = 1.092Intercept (Bablok)= -11.2893Range (X) = 66.0 - 324.0</td><td rowspan=1 colspan=1>N = 100Days = 2Correlation = 0.9995Slope (Bablok) = 1.029Intercept (Bablok) = -3.996Range (X)= 66.0 - 287.0</td></tr><tr><td rowspan=1 colspan=1>Methodcomparisonto predicate</td><td rowspan=1 colspan=1>N=59Days = 2Correlation = 0.9997Slope (Bablok) = 0.952Intercept (Bablok) = 0.5078Range (X) = 65.2 - 350.0</td><td rowspan=1 colspan=1>N = 92Days = 2Correlation = 0.9998Slope (Bablok) = 1.023Intercept (Bablok)= -3.284Range (X) = 62.2 - 330.5</td></tr><tr><td rowspan=1 colspan=1>DetectionLimits</td><td rowspan=1 colspan=1>LOB = 8.7 mmol/LLOD = 9.7 mmol/LLOQ = 13.4 mmol/L</td><td rowspan=1 colspan=1>LOB = 7.8 mmol/LLOD = 9.0 mmol/LLOQ = 18.3 mmol/L</td></tr><tr><td rowspan=1 colspan=1>StandardMeasuringrange</td><td rowspan=1 colspan=1>60-350 mmol/L</td><td rowspan=1 colspan=1>60-350 mmol/L</td></tr><tr><td rowspan=1 colspan=1>Under Range</td><td rowspan=1 colspan=1>No Extended Range</td><td rowspan=1 colspan=1>20-59.9 mmol/Lvia rerun with increase sample volume</td></tr></table>

# 510(k) Summary: cobas 8000 ISE Calibration Change and Measuring Range Extension, continued

# Evaluations summary

The cobas 8000 ISE Module, Urine Sample Type was evaluated for several performance characteristics, including repeatability, intermediate precision, LoB, LoD, LoQ, method comparison, recovery in controls, and linearity.

# Conclusion

The ISE Gen 2 reagents applied to the cobas 8000 ISE analyzer using LHH calibration and increased sample rerun mode is substantially equivalent to the predicate cobas 8000 ISE analyzer using LHSc calibration cleared under K123726.

May 22, 2014

ROCHE DIAGNOSTICS   
MR DAVID TRIBBETT   
REGULATORY AFFAIRS PRINCIPAL   
9115 HAGUE ROAD   
INDIANAPOLIS IN 46250

Re: K140373 Trade/Device Name: cobas 8000 ISE Indirect Na. K. Cl for Gen.2 Regulation Number: 21 CFR 862.1665 Regulation Name: Sodium test system Regulatory Class: 11 Product Code: JGS. CEM, CGZ Dated: May 8. 2014 Received: May 12, 2014

Dear Mr. David Tribbett:

We have reviewed your Section 5 10(k) premarket notification of intent to market the device referenc above nd hav determine the devic s substantially equivalent or the ndicatons for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. the cnactment date of the Medical Devicc Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not rcquire approval of a premarket approval application (PMA). You may, therefore. market the devicc. subjcct to the general controls provisions of the Act. The gal controls provisions o the Act inclue requirements or annual registration, listg o devices. good manufacturing practice. labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classificd (sce above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Tile 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complics with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including. but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Parts 801 and 809): medical devicc reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable. the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000- 1050.

Page 2â€”Mr. David Tribbett

If yu des peciic advice or your device on our labeling regulatons (21 CFR Pars 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address   
hutp://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/dcfault.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part .9 ar n u CFR Part 803). please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Offce of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://vww.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

# Courtney H. Lias -S

Courtney H. Lias. Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

<table><tr><td rowspan=1 colspan=1>DEPARTMENT OF HEALTH AND HUMAN SERVICESFood and Drug AdministrationIndications for Use</td><td rowspan=1 colspan=1>Form Approved: OMB No. 0910-0120Expiratlon Date: December 31, 2013See PRA Statement on last page.</td></tr><tr><td rowspan=1 colspan=2>510(k) Number (if known)k140373</td></tr><tr><td rowspan=1 colspan=2>Device Namecobas 8000 ISE Indirect Na, K. CI for Gen. 2Indicatians for Use (Descgihe)</td></tr><tr><td rowspan=1 colspan=2>Indicatians for Use (Descgihe)</td></tr></table>

Indications for Use (Describe)

T unn

# Ruth A. Chesler -S